Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-09-27
1995-05-02
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 66, 546 68, C07D45712, A61K 3148
Patent
active
054119669
ABSTRACT:
Compounds of formula I and their acid addition salts ##STR1## in which R.sup.2 R.sup.6 R.sup.13 and X have the meanings defined herein are described as well as a process and intermediates for their production, and pharmaceutical agents containing these compounds.
REFERENCES:
patent: 4137315 (1979-01-01), Farge et al.
Brumby Thomas
Loschmann Peter A.
Sauer Gerhard
Schroter Bernd
Wachtel Helmut
Kilby Scalzo Catherine S.
Richter Johann
Schering Aktiengesellschaft
LandOfFree
2, 13-disubstituted ergolines, their production and use in pharm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2, 13-disubstituted ergolines, their production and use in pharm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2, 13-disubstituted ergolines, their production and use in pharm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137253